NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

Preliminary Fiscal Q4 2026 Product Revenue of $3.8 MillionPreliminary Full-Year Product Revenue Up 15.6% to $10.5 Million, at the Top of Guidance RangeEDEN PRAIRIE, Minn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation NASDAQ:NMTC (“NeuroOne” or the “Company”), a medica…